| Literature DB >> 34418224 |
Claes Andersson1,2, Marcus Bendtsen3, Petra Lindfors4, Olof Molander5, Philip Lindner5, Naira Topooco6, Karin Engström7, Anne H Berman2,5.
Abstract
OBJECTIVES: This study evaluates whether initiation rates, completion rates, response patterns and prevalence of psychiatric conditions differ by level of personal integrity information given to prospective participants in an online mental health self-report survey.Entities:
Keywords: anonymous; confidential; mental health; online survey; personal integrity; register data
Mesh:
Year: 2021 PMID: 34418224 PMCID: PMC8633924 DOI: 10.1002/mpr.1891
Source DB: PubMed Journal: Int J Methods Psychiatr Res ISSN: 1049-8931 Impact factor: 4.035
FIGURE 1Group‐specific information provided in invitation email and study information
FIGURE 2Four levels of group comparisons
FIGURE 3Participant flow. a = Percent of those who received email. b = Percent of those who proceeded to study information. c = Percent of those who provided consent. Italicized numbers indicate participants who did not proceed to the next step, thereby abandoning the survey
Group comparisons of proportions of participants who pressed a hyperlink provided in emails to reach a webpage providing group‐specific study information, and proportions of participants providing informed consent
| Bayesian marginal posterior distribution | Maximum Likelihood estimates and null hypothesis testing | ||||
|---|---|---|---|---|---|
| Median (2.5%; 97.5%) | OR < 1 | OR estimate (95% CI) |
| ||
| Study information | Group 2 vs. Group 1 | 0.98 (0.89; 1.09) | 61.9% | 0.98 (0.89; 1.09) | 0.76 |
| Group 3 vs. Group 1 | 0.98 (0.89; 1.09) | 63.8% | 0.98 (0.89; 1.09) | 0.73 | |
| Group 3 vs. Group 2 | 1.00 (0.90; 1.11) | 52.8% | 1.00 (0.90; 1.11) | 0.97 | |
| Informed consent | Group 2 vs. Group 1 | 0.73 (0.58; 0.90) | 99.8% | 0.72 (0.58; 0.90) | <0.01 |
| Group 3 vs. Group 1 | 0.81 (0.65; 1.02) | 96.3% | 0.81 (0.65; 1.01) | 0.063 | |
| Group 3 vs. Group 2 | 1.12 (0.90; 1.38) | 15.2% | 1.12 (0.90; 1.39) | 0.31 | |
Note: Group 1 = anonymous response; Group 2 = confidential arm with personally identified data; Group 3 = confidential arm with personally identified data and linkage to register data. Second group is reference group.
Cumulative proportions abandoning the questionnaire per question presented
| Bayesian marginal posterior distribution | |||||
|---|---|---|---|---|---|
| Subset 1: Consented and initiated survey ( | Subset 2: Completers excluded ( | ||||
| Median (2.5%; 97.5%) | HR > 1 | Median (2.5%; 97.5%) | HR > 1 | ||
| Group 1 | Baseline hazard | 0.018 (0.014; 0.022) | ‐ | 0.072 (0.049; 0.105) | ‐ |
| Group 2 | Hazard ratio | 0.94 (0.84; 1.05) | 12.3% | 0.98 (0.82; 1.17) | 41.3% |
| Group 3 | Hazard ratio | 0.95 (0.85; 1.06) | 18.2% | 1.05 (0.88; 1.26) | 71.5% |
Note: Proportional hazard regression with adjustments for gender identity and age. Group 1 = anonymous response; Group 2 = confidential arm with personally identified data; Group 3 = confidential arm with personally identified data and linkage to register data.
Proportions of positive screens and group‐comparisons of proportions screening positive for eight psychiatric disorders
| Positive screens | Group‐comparison | |||||||
|---|---|---|---|---|---|---|---|---|
| % ( | Chi‐2 | Bayesian marginal posterior distribution | Maximum likelihood estimates and null hypothesis testing | |||||
|
| Median (2.5%; 97.5%) | OR < 1 | OR estimate (95% CI) |
| ||||
| Depression | Total | 56.3 (937/1664) | ||||||
| Group 2 vs. Group 1 | 53.7 (286/533) | 59.7 (339/568) | 0.044 | 0.78 (0.61; 0.99) | 97.8% | 0.78 (0.61; 0.99) | 0.045 | |
| Group 3 vs. Group 1 | 55.4 (312/563) | 59.7 (339/568) | 0.15 | 0.84 (0.61; 1.07) | 92.1% | 0.84 (0.66; 1.06) | 0.15 | |
| Group 3 vs. Group 2 | 55.4 (312/563) | 53.7 (286/533) | 0.56 | 1.07 (0.84; 1.35) | 27.8% | 1.07 (0.84; 1.36) | 0.57 | |
| Anxiety | Total | 76.3 (1277/1673) | ||||||
| Group 2 vs. Group 1 | 76.6 (410/535) | 76.4 (438/573) | 0.94 | 1.03 (0.78; 1.36) | 42.7% | 1.03 (0.77; 1.36) | 0.86 | |
| Group 3 vs. Group 1 | 75.9 (429/565) | 76.4 (438/573) | 0.84 | 0.99 (0.75; 1.29) | 53.9% | 0.99 (0.75; 1.30) | 0.92 | |
| Group 3 vs. Group 2 | 75.9 (429/565) | 76.6 (410/535) | 0.79 | 0.95 (0.72; 1.26) | 63.5% | 0.95 (0.71; 1.26) | 0.72 | |
| Bipolar disorder | Total | 21.9 (277/1262) | ||||||
| Group 2 vs. Group 1 | 22.7 (92/431) | 21.3 (92/431) | 0.65 | 1.07 (0.77; 1.48) | 33.4% | 1.07 (0.77; 1.49) | 0.67 | |
| Group 3 vs. Group 1 | 21.9 (93/425) | 21.3 (92/431) | 0.85 | 1.01 (0.73; 1.41) | 47.1% | 1.01 (0.73; 1.41) | 0.93 | |
| Group 3 vs. Group 2 | 21.9 (93/425) | 22.7 (92/431) | 0.79 | 0.95 (0.69; 1.31) | 62.0% | 0.95 (0.68; 1.32) | 0.75 | |
| Panic attacks | Total | 50.6 (678/1341) | ||||||
| Group 2 vs. Group 1 | 48.7 (209/429) | 50.8 (235/463) | 0.54 | 0.94 (0.73; 1.23) | 66.6% | 0.94 (0.72; 1.23) | 0.67 | |
| Group 3 vs. Group 1 | 51.1 (234/449) | 50.8 (235/463) | 0.68 | 1.07 (0.83; 1.39) | 29.1% | 1.07 (0.82; 1.40) | 0.60 | |
| Group 3 vs. Group 2 | 51.1 (234/449) | 48.7 (209/429) | 0.31 | 1.15 (0.88; 1.49) | 16.2% | 1.15 (0.88; 1.50) | 0.32 | |
| Post‐traumatic stress disorder | Total | 61.7 (819/1327) | ||||||
| Group 2 vs. Group 1 | 62.1 (267/430) | 61.4 (277/451) | 0.84 | 1.04 (0.79; 1.36) | 37.9% | 1.04 (0.79; 1.37) | 0.76 | |
| Group 3 vs. Group 1 | 61.7 (275/446) | 61.4 (277/451) | 0.94 | 1.04 (0.80; 1.36) | 38.0% | 1.04 (0.79; 1.37) | 0.77 | |
| Group 3 vs. Group 2 | 61.7 (275/446) | 62.1 (267/430) | 0.89 | 0.99 (0.75; 1.30) | 53.0% | 0.99 (0.75; 1.30) | 0.93 | |
| Self‐harm | Total | 61.5 (783/1274) | ||||||
| Group 2 vs. Group 1 | 60.0 (252/420) | 62.1 (265/427) | 0.54 | 0.92 (0.70; 1.22) | 72.0% | 0.92 (0.70; 1.22) | 0.56 | |
| Group 3 vs. Group 1 | 62.3 (266/427) | 62.1 (265/427) | 0.94 | 0.99 (0.75; 1.31) | 52.2% | 0.99 (0.75; 1.31) | 0.94 | |
| Group 3 vs. Group 2 | 62.3 (266/427) | 60.0 (252/420) | 0.49 | 1.08 (0.82; 1.43) | 28.9% | 1.08 (0.82; 1.43) | 0.59 | |
| Alcohol use disorder | Total | 71.7 (929/1295) | ||||||
| Group 2 vs. Group 1 | 70.0 (297/424) | 72.1 (316/438) | 0.50 | 0.91 (0.68; 1.22) | 72.4% | 0.92 (0.68; 1.23) | 0.56 | |
| Group 3 vs. Group 1 | 73.0 (316/433) | 72.1 (316/438) | 0.78 | 1.05 (0.78; 1.41) | 37.4% | 1.06 (0.78; 1.43) | 0.73 | |
| Group 3 vs. Group 2 | 73.0 (316/433) | 70.0 (297/424) | 0.34 | 1.17 (0.87; 1.57) | 15.0% | 1.18 (0.87; 1.59) | 0.29 | |
| Drug use | Total | 34.8 (447/1286) | ||||||
| Group 2 vs. Group 1 | 34.1 (144/422) | 36.2 (158/436) | 0.52 | 0.90 (0.68; 1.19) | 77.9% | 0.89 (0.67; 1.18) | 0.43 | |
| Group 3 vs. Group 1 | 33.9 (145/428) | 36.2 (158/436) | 0.47 | 0.87 (0.66; 1.16) | 82.6% | 0.87 (0.65; 1.15) | 0.33 | |
| Group 3 vs. Group 2 | 33.9 (145/428) | 34.1 (144/422) | 0.94 | 0.98 (0.74; 1.31) | 55.5% | 0.98 (0.73; 1.31) | 0.90 | |
Note: Logistic regression with adjustments for gender identity and age. Group 1 = anonymous response; Group 2 = confidential arm with personally identified data; Group 3 = confidential arm with personally identified data and linkage to register data. Second group is reference group.